Cargando…
Impact of the biological definition of Alzheimer’s disease using amyloid, tau and neurodegeneration (ATN): what about the role of vascular changes, inflammation, Lewy body pathology?
BACKGROUND: The NIA-AA research framework proposes a biological definition of Alzheimer’s disease, where asymptomatic persons with amyloid deposition would be considered as having this disease prior to symptoms. DISCUSSION: Notwithstanding the fact that amyloid deposition in isolation is not associa...
Autores principales: | Gauthier, S., Zhang, H., Ng, K. P., Pascoal, T.A., Rosa-Neto, P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5977549/ https://www.ncbi.nlm.nih.gov/pubmed/29876101 http://dx.doi.org/10.1186/s40035-018-0117-9 |
Ejemplares similares
-
Prognostic value of amyloid/tau/neurodegeneration (ATN) classification based on diagnostic cerebrospinal fluid samples for Alzheimer’s disease
por: Delmotte, Koen, et al.
Publicado: (2021) -
Dissociation of tau pathology and neuronal hypometabolism within the ATN framework of Alzheimer’s disease
por: Duong, Michael Tran, et al.
Publicado: (2022) -
Preclinical amyloid pathology biomarker positivity: effects on tau pathology and neurodegeneration
por: Höglund, K, et al.
Publicado: (2017) -
Pathway Analysis for Plasma β-Amyloid, Tau and Neurofilament Light (ATN) in World Trade Center Responders at Midlife
por: Kritikos, Minos, et al.
Publicado: (2020) -
Amyloid-β and hyperphosphorylated tau synergy drives metabolic decline in preclinical Alzheimer's disease
por: Pascoal, T A, et al.
Publicado: (2017)